…with relapsed B-ALL after blinatumomab who failed to respond to autologous CD19-targeted CAR-T cell therapy and mitoxantrone-based reinduction chemotherapy. The patient ac…
4articles mentioning treatments
4treatment mentions
1distinct treatments extracted
0%of mentions human-reviewed
chimeric antigen receptor T (CAR-T) cell therapy
This treatment is selected. Its supporting articles are shown below.
Articles mentioning chimeric antigen receptor T (CAR-T) cell therapy
4 articles · page 1 of 1autologous CD19-targeted CAR-T cell therapychimeric antigen receptor T (CAR-T) cell therapymitoxantrone-based reinduction chemotherapyblinatumomabB-cell acute lymphoblastic leukemiaB-ALL
chimeric antigen receptor T (CAR-T) cell therapysolid tumorscancergranzyme B
…Background Boosting the performance of chimeric antigen receptor T (CAR-T) cell therapy in solid tumors may provide a substantial advantage for patient…
Chimeric Antigen Receptor T (CAR-T) cell therapysolid tumourshaematological malignanciesEuropean Research CouncilERCanticancer drugsMinisterio de Educacion y Formacion ProfesionalHorizon 2020 research and innovation programmesolid tumorsICoMICS
…Background Chimeric Antigen Receptor T (CAR-T) cell therapy has demonstrated remarkable success in treating haematological …
Chimeric Antigen Receptor T (CAR-T) cell therapyhematologic malignanciessolid tumors
…Background Chimeric Antigen Receptor T (CAR-T) cell therapy has emerged as an advanced and highly effective approach for tr…